PMID- 27885460
OWN - NLM
STAT- MEDLINE
DCOM- 20170710
LR  - 20181113
IS  - 1573-2568 (Electronic)
IS  - 0163-2116 (Linking)
VI  - 62
IP  - 1
DP  - 2017 Jan
TI  - Contraceptive Considerations for Women with Gastrointestinal Disorders.
PG  - 54-63
LID - 10.1007/s10620-016-4383-z [doi]
AB  - Gastroenterologists are in a unique position to assist women with chronic
      gastrointestinal disorders in order to optimize their health prior to pregnancy. 
      Women, whether with chronic conditions or not, and their infants are more likely 
      to be healthy when pregnancies are planned. Achieving a planned pregnancy at the 
      ideal time or preventing pregnancy altogether requires the use of appropriate
      contraceptives. There is a broad range of contraceptives available to women in
      the USA, and the majority of women with digestive diseases will be candidates for
      all effective methods. Guidance from the Centers for Disease Control and
      Prevention aids clinicians in prescribing appropriate contraceptives to women
      with medical disorders. This review will focus on contraception for women with
      inflammatory bowel disease and chronic liver disease, including liver transplant.
FAU - Sridhar, Aparna
AU  - Sridhar A
AD  - The Department of Obstetrics and Gynecology, David Geffen School of Medicine at
      UCLA, 10833 Le Conte Ave CHS 22-229, Los Angeles, CA, 90095, USA.
FAU - Cwiak, Carrie A
AU  - Cwiak CA
AD  - The Department of Gynecology and Obstetrics, Emory University School of Medicine,
      49 Jesse Hill Jr. Drive SE, Atlanta, GA, 30303, USA.
FAU - Kaunitz, Andrew M
AU  - Kaunitz AM
AD  - Department of Obstetrics and Gynecology, University of Florida College of
      Medicine-Jacksonville, 653-1 W. 8th Street, Jacksonville, FL, 32209, USA.
FAU - Allen, Rebecca H
AU  - Allen RH
AUID- ORCID: 0000-0002-6418-9426
AD  - The Department of Obstetrics and Gynecology, Warren Alpert Medical School of
      Brown University, 101 Dudley Street, Providence, RI, 02905, USA.
      rhallen@wihri.org.
LA  - eng
PT  - Journal Article
PT  - Review
PT  - Research Support, Non-U.S. Gov't
DEP - 20161124
PL  - United States
TA  - Dig Dis Sci
JT  - Digestive diseases and sciences
JID - 7902782
RN  - 0 (Contraceptive Agents, Female)
RN  - 0 (Contraceptives, Oral, Combined)
RN  - 0 (Contraceptives, Oral, Hormonal)
RN  - 5W7SIA7YZW (Levonorgestrel)
SB  - AIM
SB  - IM
MH  - Colitis, Ulcerative
MH  - Contraception/*methods
MH  - Contraceptive Agents, Female/therapeutic use
MH  - Contraceptives, Oral, Combined/therapeutic use
MH  - Contraceptives, Oral, Hormonal/therapeutic use
MH  - Crohn Disease
MH  - Digestive System Diseases
MH  - Disease Management
MH  - Female
MH  - Humans
MH  - *Inflammatory Bowel Diseases
MH  - Intrauterine Devices, Medicated
MH  - Levonorgestrel/therapeutic use
MH  - *Liver Cirrhosis
MH  - Liver Transplantation
OTO - NOTNLM
OT  - *Cirrhosis
OT  - *Contraception
OT  - *Crohn's disease
OT  - *Inflammatory bowel disease
OT  - *Liver transplantation
OT  - *Ulcerative colitis
EDAT- 2016/11/26 06:00
MHDA- 2017/07/14 06:00
CRDT- 2016/11/26 06:00
PHST- 2016/03/21 00:00 [received]
PHST- 2016/11/15 00:00 [accepted]
PHST- 2016/11/26 06:00 [pubmed]
PHST- 2017/07/14 06:00 [medline]
PHST- 2016/11/26 06:00 [entrez]
AID - 10.1007/s10620-016-4383-z [doi]
AID - 10.1007/s10620-016-4383-z [pii]
PST - ppublish
SO  - Dig Dis Sci. 2017 Jan;62(1):54-63. doi: 10.1007/s10620-016-4383-z. Epub 2016 Nov 
      24.